A new animal study out of the Washington University School of Medicine indicates that disruptions in an individual’s sleep-wake cycle may be an early indicator of Alzheimer’s disease.
Scientists measured amyloid plaques, one of the defining brain abnormalities associated with Alzheimer’s disease, in mice that were genetically altered to develop these Alzheimer’s plaques as they age. Researchers found that when the first indicators of these plaques began to appear, mice began experiencing a change in their sleep patterns. Mice generally sleep 40 minutes during every hour of daylight, but when the plaques began forming the mice averaged just 30 minutes of sleep during every hour of daylight. In aging mice that did not develop Alzheimer’s plaques, no change in sleep patterns was observed.
“If sleep abnormalities begin this early in the course of human Alzheimer’s disease, those changes could provide us with an easily detectable sign of pathology,” says senior author David M. Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor and head of Washington University’s Department of Neurology. “As we start to treat Alzheimer’s patients before the onset of dementia, the presence or absence of sleep problems may be a rapid indicator of whether the new treatments are succeeding.”
More research will be needed to establish a cause and effect relationship or prove this correlation in humans, but previous studies have found that amyloid levels and plaques behave similarly in both humans and mice.
Read more about the Alzheimer's disease study, including an audio overview of the findings.
Business Planning, Dining, Memory Care Best Practices and Research, Memory Care Education, Property Management, Value-Added Amenities and Services
As Alzheimer’s becomes more prevalent among the nation’s older adults, senior living communities are creating innovative ways to create nurturing envi...
All About Alzheimer’s: A Look at Tests, Ethnicities, Diabetes, Drugs and Dementia-Friendly Communities
Facts and Figures, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports
Errors on memory and thinking tests could signal Alzheimer’s disease up to 18 years before diagnosis, according to a new study from Rush University re...
cheatsheet, Family Relations, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Partnerships
ALFA is partnering with US Against Alzheimer’s to support Dementia Friendly America, a new national initiative to build a more dementia-friendly natio...
Elder Abuse, Hearings, Medication Management, Memory Care Best Practices and Research, Memory Care Education
A top lawmaker on the Senate Special Committee on Aging has launched an examination of products, regulations and retailers in the dietary supplement i...
Business Planning, Featured Magazine Articles, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Wellness Program
Providers leverage the latest research on physical exercise, sensory inputs, and more to provide better resident care and delay the onset of Alzheimer...
Engage, Memory Care Best Practices and Research, Memory Care Education
Hearthstone’s founder, John Zeisel, is broadcasting a new show on a local Massachusetts cable station called “Hopeful Aging with Dr. John Zeisel.” The...
End of Life, Health and Wellness, Medication Management, Memory Care Best Practices and Research, Memory Care Education
Doctors discuss optimal eating plans for a woman with early stage Alzheimer’s disease in a CulinaryRx case report. In a lightly edited transcript from...
Facts and Figures, Memory Care Best Practices and Research, Reports
Dementia disproportionately affects women throughout the world and countries need to develop health and social care policies based on evidence of need...
The National Institutes of Health recently released recommendations providing a framework for an Alzheimer’s disease research agenda that was develope...
End of Life, Federal Agency Activity, Managed Risk, Medication Management, Memory Care Best Practices and Research
Federal and state policies generally encourage the use of available generic drug products as do private payers such as insurers and others, which is w...